OSR Health, Inc. (OSRH)
NASDAQ: OSRH · Real-Time Price · USD
0.2500
-0.0270 (-9.75%)
At close: Aug 24, 2026, 4:00 PM EDT
0.2298
-0.0202 (-8.08%)
After-hours: Aug 24, 2026, 7:37 PM EDT
OSR Health Employees
OSR Health had 22 employees as of December 31, 2025. The number of employees increased by 1 or 4.76% compared to the previous year.
Employees
22
Change (1Y)
1
Growth (1Y)
4.76%
Revenue / Employee
$82,216
Profits / Employee
-$487,721
Market Cap
8.78M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 22 | 1 | 4.76% | 22 | 0 |
| Dec 31, 2024 | 21 | - | - | 19 | 2 |
Related Stocks
| Company Name | Employees |
|---|---|
| Lunai Bioworks | 29 |
| Imunon | 20 |
| FibroBiologics | 15 |
| Soligenix | 14 |
| Azitra | 13 |
| CNS Pharmaceuticals | 8 |
| Immuron | 7 |
| Traws Pharma | 7 |
OSRH News
- 3 days ago - OSR Health: Preparing Our Appeal, Advancing Our Catalysts, Continuing Our Mission - Accesswire
- 5 days ago - OSR Health Receives Nasdaq Staff Delisting Determination and Intends to Request Hearings Panel Appeal - Accesswire
- 5 days ago - OSR Health Sees Global Shareholder Momentum at Critical Inflection Point - Accesswire
- 13 days ago - OSR Health CEO Reaffirms Confidence and Highlights Subsidiary Business Development - Accesswire
- 17 days ago - OSR Health Issues Clarification Regarding Prior Nasdaq Communication and Shareholder Loyalty CVR Program - Accesswire
- 21 days ago - Vaximm AG, an OSR Company, Announces Forthcoming Publication of Cross-Indication Clinical Data for VXM01, Its VEGFR-2-Targeted Cancer Vaccine Platform - Accesswire
- 24 days ago - OSR Health Secures Nasdaq Communication: Loyalty CVR Program Will Not Trigger a Price Adjustment - Accesswire
- 6 weeks ago - OSR Health, A Message From the CEO - Accesswire